axicabtagene ciloleucel,tisagenlecleucel
gilead,novartis,daiichi sankyo
['elevate,(-elevate uc),(-elevateuc),(-elevate-uc),(-elevate rr),(-elevaterr),(-elevate-rr),(-elevate tn),(-elevatetn),(-elevate-tn)', 'axi-cel', 'tisa-cel', 'axicabtagene ciloleucel', 'lymsm', 'lymphoma', 'dlbcl', 'tisagenlecleucel']
des-car-t post-car-t dlbcl relapse cohort - 145 patients with late failures #ash22 #lymsm 
haematology registrar | fellow @PORTAL_research @harvardmed |
evidence-based medicine | health policy | lymphoma | myeloma |
Fulbright scholar | muso | writer